mk 0663 has been researched along with Polyarthritis in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (80.95) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atre, B; Balap, A; Lohidasan, S; Mahadik, K; Sinnathambi, A | 1 |
| Arora, SK; Khanduja, KL; Medhi, B; Pandhi, P; Rao, RS; Saikia, UN; Toor, JS | 1 |
| Diza, E; Gika, HG; Michopoulos, F; Nikolaidis, P; Settas, L; Smith, C; Theodoridis, G; Theodoridou, A; Wilson, ID | 1 |
| Brater, DC; Cannon, CP; Curtis, SP; Kaur, A; Krum, H; Laine, L; Smugar, SS; Wang, H; Weir, MR | 1 |
| Cannon, CP; Cryer, B; Curtis, SP; Kaur, A; Laine, L | 2 |
| Brater, DC; Cannon, CP; Curtis, SP; Gammaitoni, A; Kaur, A; Krum, H; Laine, L; Peloso, PM; Smugar, SS; Swergold, G; Wang, H; Weir, MR | 1 |
| Cochrane, DJ; Jarvis, B; Keating, GM | 1 |
| Capell, HA; Duncan, MR | 1 |
| Cavanaugh, PF; Matsumoto, AK | 1 |
| Cavanaugh, PF; Dougados, M; Gossec, L; James, MK; Krupa, DA; Melian, A; Reicin, AS; van der Heijde, D | 1 |
| Martina, SD; Ripley, TL; Vesta, KS | 1 |
| Krüger, K | 1 |
| Lee, W; Weisman, MH | 1 |
| Broich, K; Heim, HK | 1 |
| Patrignani, P; Rodríguez, LA | 1 |
| Tabrizchi, R | 1 |
| Young, D | 1 |
| Navarra, S; Rubin, BR; Smugar, SS; Tershakovec, AM; Yu, Q | 1 |
| Nikkels, AF; Piérard, GE; Thirion, L | 1 |
5 review(s) available for mk 0663 and Polyarthritis
| Article | Year |
|---|---|
Etoricoxib.
Topics: Administration, Oral; Arthritis; Back Pain; Clinical Trials as Topic; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoricoxib; Gout; Humans; Isoenzymes; Membrane Proteins; Oral Surgical Procedures; Pain, Postoperative; Prostaglandin-Endoperoxide Synthases; Pyridines; Sulfones | 2002 |
Etoricoxib.
Topics: Arthritis; Clinical Trials as Topic; Cyclooxygenase 2; Etoricoxib; Hemarthrosis; Hemophilia A; Humans; Isoenzymes; Membrane Proteins; Pain; Prostaglandin-Endoperoxide Synthases; Pyridines; Spondylitis, Ankylosing; Sulfones | 2004 |
Etoricoxib: a highly selective COX-2 inhibitor.
Topics: Adult; Arthritis; Biological Availability; Cyclooxygenase Inhibitors; Dysmenorrhea; Etoricoxib; Female; Half-Life; Humans; Low Back Pain; Male; Middle Aged; Pain; Pyridines; Randomized Controlled Trials as Topic; Stomach Ulcer; Sulfones | 2005 |
[The efficacy of selective Cox-2-inhibitors in comparison with conventional NSAIDs].
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Celecoxib; Controlled Clinical Trials as Topic; Cyclooxygenase Inhibitors; Etoricoxib; Gout; Humans; Osteoarthritis; Placebos; Pyrazoles; Pyridines; Rheumatic Diseases; Spondylitis, Ankylosing; Sulfonamides; Sulfones | 2005 |
Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Aspirin; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Etoricoxib; Female; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Osteoarthritis; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Pyridines; Sulfones | 2007 |
6 trial(s) available for mk 0663 and Polyarthritis
| Article | Year |
|---|---|
Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program.
Topics: Aged; Arthritis; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Etoricoxib; Female; Follow-Up Studies; Heart Failure; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Pyridines; Retrospective Studies; Risk Factors; Sulfones | 2009 |
Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pyridines; Risk Factors; Sulfones; Time Factors; Upper Gastrointestinal Tract | 2010 |
Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugs.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Blood Pressure; Body Weight; Comorbidity; Cyclooxygenase 2 Inhibitors; Diclofenac; Double-Blind Method; Etoricoxib; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Pyridines; Racial Groups; Risk Assessment; Sulfones; Thrombosis | 2012 |
Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Chronic Disease; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Naproxen; Pain Measurement; Pyridines; Severity of Illness Index; Spondylitis, Ankylosing; Sulfones; Treatment Outcome | 2005 |
Treating axial manifestations in ankylosing spondylitis in the presence of peripheral arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Etoricoxib; Follow-Up Studies; Humans; Naproxen; Pain Measurement; Pyridines; Spondylitis, Ankylosing; Sulfones; Treatment Outcome | 2006 |
Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout.
Topics: Acute Disease; Adult; Arthralgia; Arthritis; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Resistance; Etoricoxib; Female; Gout; Gout Suppressants; Humans; Indomethacin; Male; Middle Aged; Pyridines; Sulfones | 2007 |
10 other study(ies) available for mk 0663 and Polyarthritis
| Article | Year |
|---|---|
[Non-selective NSAIDs and coxibs: what are myths, what are facts?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoricoxib; Humans; Long-Term Care; Osteoarthritis; Pain; Pain Management; Pyridines; Sulfones; Treatment Outcome | 2013 |
Pharmacokinetic and pharmacodynamic herb-drug interaction of Andrographis paniculata (Nees) extract and andrographolide with etoricoxib after oral administration in rats.
Topics: Administration, Oral; Andrographis; Animals; Anti-Inflammatory Agents; Antioxidants; Arthritis; Chromatography, High Pressure Liquid; Diterpenes; Etoricoxib; Female; Herb-Drug Interactions; Plant Extracts; Plants, Medicinal; Pyridines; Rats; Rats, Wistar; Sulfones | 2016 |
Experimentally induced various inflammatory models and seizure: understanding the role of cytokine in rat.
Topics: Acetic Acid; Analysis of Variance; Animals; Arthritis; Colitis; Cyclooxygenase Inhibitors; Cytokines; Disease Models, Animal; DNA Fragmentation; Etoricoxib; Freund's Adjuvant; Immunosuppressive Agents; Inflammation; Male; Pyridines; Rats; Rats, Wistar; Seizures; Sulfones; Thalidomide | 2008 |
Determination of two COX-2 inhibitors in serum and synovial fluid of patients with inflammatory arthritis by ultra performance liquid chromatography-inductively coupled plasma mass spectroscopy and quadrupole time-of-flight mass spectrometry.
Topics: Adult; Aged; Arthritis; Celecoxib; Chromatography, High Pressure Liquid; Cyclooxygenase 2 Inhibitors; Etoricoxib; Female; Humans; Male; Mass Spectrometry; Middle Aged; Pyrazoles; Pyridines; Reference Standards; Spectrometry, Mass, Electrospray Ionization; Sulfonamides; Sulfones; Synovial Fluid; Young Adult | 2009 |
Etoricoxib in the treatment of chronic pain.
Topics: Adult; Aged; Arthritis; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Double-Blind Method; Etoricoxib; Gastrointestinal Diseases; Humans; Low Back Pain; Middle Aged; Pain; Pyridines; Randomized Controlled Trials as Topic; Sulfones | 2003 |
Selective COX-2 inhibitors and risk of thromboembolic events - regulatory aspects.
Topics: Adverse Drug Reaction Reporting Systems; Animals; Arthritis; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Approval; Drug Evaluation, Preclinical; Etoricoxib; European Union; Humans; Lactones; Product Surveillance, Postmarketing; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Risk Assessment; Sulfonamides; Sulfones; Thromboembolism | 2006 |
The ever growing story of cyclo-oxygenase inhibition.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Etoricoxib; Humans; Pyridines; Randomized Controlled Trials as Topic; Sulfones | 2006 |
Coxibs: can this class of drugs survive?
Topics: Arthritis; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Etoricoxib; Evidence-Based Medicine; Half-Life; Humans; Isoxazoles; Lactones; Patient Selection; Pyrazoles; Pyridines; Sulfonamides; Sulfones | 2005 |
Few options available for arthritis pain relief. FDA declines to approve Merck's Arcoxia.
Topics: Arthritis; Cyclooxygenase 2 Inhibitors; Drug Approval; Drug Industry; Etoricoxib; Humans; Pyridines; Sulfones; United States; United States Food and Drug Administration | 2007 |
Etoricoxib-induced erythema-multiforme-like eruption.
Topics: Aged; Arthritis; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Erythema Multiforme; Etoricoxib; Humans; Male; Pyridines; Skin; Sulfones | 2008 |